1. Home
  2. FA vs AMPH Comparison

FA vs AMPH Comparison

Compare FA & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FA
  • AMPH
  • Stock Information
  • Founded
  • FA 2003
  • AMPH 1996
  • Country
  • FA United States
  • AMPH United States
  • Employees
  • FA N/A
  • AMPH N/A
  • Industry
  • FA Business Services
  • AMPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • FA Consumer Discretionary
  • AMPH Health Care
  • Exchange
  • FA Nasdaq
  • AMPH Nasdaq
  • Market Cap
  • FA 2.9B
  • AMPH 2.5B
  • IPO Year
  • FA 2021
  • AMPH 2014
  • Fundamental
  • Price
  • FA $18.55
  • AMPH $44.55
  • Analyst Decision
  • FA Buy
  • AMPH Buy
  • Analyst Count
  • FA 8
  • AMPH 4
  • Target Price
  • FA $20.80
  • AMPH $63.00
  • AVG Volume (30 Days)
  • FA 1.4M
  • AMPH 404.9K
  • Earning Date
  • FA 11-12-2024
  • AMPH 11-06-2024
  • Dividend Yield
  • FA N/A
  • AMPH N/A
  • EPS Growth
  • FA N/A
  • AMPH 17.38
  • EPS
  • FA 0.03
  • AMPH 3.01
  • Revenue
  • FA $755,643,000.00
  • AMPH $723,549,000.00
  • Revenue This Year
  • FA $4.07
  • AMPH $17.23
  • Revenue Next Year
  • FA $7.48
  • AMPH $10.25
  • P/E Ratio
  • FA $545.91
  • AMPH $14.78
  • Revenue Growth
  • FA N/A
  • AMPH 20.33
  • 52 Week Low
  • FA $13.88
  • AMPH $36.56
  • 52 Week High
  • FA $20.79
  • AMPH $65.92
  • Technical
  • Relative Strength Index (RSI)
  • FA 52.42
  • AMPH 38.65
  • Support Level
  • FA $17.10
  • AMPH $43.09
  • Resistance Level
  • FA $20.79
  • AMPH $49.53
  • Average True Range (ATR)
  • FA 0.72
  • AMPH 1.76
  • MACD
  • FA 0.06
  • AMPH -0.62
  • Stochastic Oscillator
  • FA 39.30
  • AMPH 13.43

About FA First Advantage Corporation

First Advantage Corp is a provider of employment background screening and verification solutions. The company delivers services and insights that help its customers manage risk and hire talent. The Company has two reportable segments, Americas and International. The Americas segment provides technology solutions for screening, verifications, safety, and compliance in the United States, Canada, and Latin America markets. and the International segment provides technology solutions for screening, verifications, safety, and compliance outside of the Americas. The company derives its maximum revenue from America.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: